MANDALMED
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a family of carbohydrate binding proteins. The lead product is MM-003, a protein inhibitor of galectin-3, for prevention and reversal of fibrosis after myocardial infarction and in heart failure
MANDALMED
Social Links:
Industry:
Biotechnology Health Care
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.mandalmed.com
Total Employee:
1+
Status:
Active
Contact:
(415) 495-5570
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart
Current Employees Featured
Founder
Official Site Inspections
http://www.mandalmed.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "MandalMed"
MandalMed, Inc
Our mission is to translate breakthroughs in fibrosis research into therapies for patients with unmet medical needs. (c) Copyright MandalMed, Inc. 2019-2022. All Rights Reserved.See details»
About — MandalMed, Inc
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a …See details»
Company Overview - MandalMed, Inc
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a family of carbohydrate binding proteins.See details»
MandalMed Company Profile 2024: Valuation, Funding …
MandalMed General Information Description Operator of a biotechnology company intended to develop treatments for organ fibrosis through modulation of glycobiology and innate immunity.See details»
MandalMed - Crunchbase Company Profile & Funding
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target …See details»
MANDALMED, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MANDALMED, INC. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
MANDALMED, INC. - LinkedIn
MANDALMED, INC. | 42 followers on LinkedIn. MANDALMED, INC. is a biotechnology company based in San Francisco, California.See details»
Firm | SBIR
The human Sertoli cells have been isolated from normal human testis tissue by MandalMed scientists using a novel patent-pending methodology. To our knowledge, due to difficulty in …See details»
Our Team — MandalMed, Inc
Gregory Porter of Silverman, Krantz, and Porter in San Francisco has performed accounting services for MandalMed since the Company was founded. Silverman, Krantz, and Porter offers a wide range of services to individual and business …See details»
MANDALMED, INC. Overview | SignalHire Company Profile
Overview. Contact top employees from MANDALMED, INC. Summary. MANDALMED, INC. is a private company. The company currently specializes in the Biotechnology area. Its …See details»
MandalMed - Overview, News & Similar companies | ZoomInfo.com
MandalMed contact info: Phone number: (415) 495-5570 Website: www.mandalmed.com What does MandalMed do? MandalMed is a privately held biotechnology company located in San …See details»
MandalMed - Contacts, Employees, Board Members, Advisors
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis.See details»
Mandalmed, Inc. Details - govtribe.com
Nov 21, 2005 · MandalMed focuses on transforming innovative medical breakthroughs into effective healing products for the healthcare industry. - https://mandalmed.comSee details»
Constance M John - Founder & CEO @ MandalMed - Crunchbase
Constance M John is the Founder and CEO at MandalMed, Inc. Constance M John attended the University of California, San Francisco.See details»
Research & Development — MandalMed, Inc
MandalMed’s lead product is MM-003, a human protein that is an inhibitor of galectin-3, which is being developed to prevent and treat harmful remodeling after myocardial infarction (MI; heart …See details»
MandalMed - VentureRadar
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a …See details»
News and Events — MandalMed, Inc
Aug 15, 2016 · MandalMed Contracts with Lonza to be Sole Distributor of Proprietary Human Sertoli Cells. May 2009 MandalMed announces an agreement with Lonza, a foremost supplier …See details»
MandalMed - Crunchbase
MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis.See details»
Research programme: regenerative cell therapy - MandalMed
MandalMed, in collaboration with the University of California at San Francisco, is developing a regenerative ex vivo gene/cell therapy for the treatment of.See details»
Contact Us - MandalMed, Inc
Contact Us — MandalMed, Inc. Use the form below to reach out to us, or you can reach us by telephone at (415) 495-5570. Name (required) First Name. Last Name. Email (required) …See details»